Abstract:Background: The protein p53, encoded by the most frequently mutated gene TP53 in human cancers, has diverse functions in tumor suppression. As a best known transcription factor, p53 can regulate various fundamental cellular responses, ranging from the cell-cycle arrest, DNA repair, senescence to the programmed cell death (PCD), which includes autophagy, apoptosis, ferroptosis, cuproptosis, pyroptosis and disulfidoptosis. Accumulating evidence has indicated that the tumor microenvironment (TME), N6-methyladenosine (m6A) modification and diverse PCD are important for the progression, proliferation and metastases of cancers. Aim of review: This paper aims to systematically and comprehensively summarize the multiple roles of p53 in the development of cancers from the regulation of TME, m6A Modification and diverse PCD. Key scientific concepts of review: TME, a crucial local homeostasis environment, influences every step of tumorigenesis and metastasis. m6A, the most prevalent and abundant endogenous modification in eukaryotic RNAs, plays an essential role in various biological processes, containing the progression of cancers. Additionally, PCD is an evolutionarily conserved mechanism of cell suicide and a common process in living organisms. Some forms of PCD contribute to the occurrence and development of cancer. However, the complex roles of p53 within the TME, m6A modification and diverse PCD mechanisms are still not completely understood. Presently, the function roles of p53 including the wild-type and mutant p53 in different context are summarized. Additionally, the interaction between the cancer immunity, cancer cell death and RNA m6A methylation and the p53 regulation during the development and progress of cancers were discussed. Moreover, the key molecular mechanisms by which p53 participates in the regulation of TME, m6A and diverse PCD are also explored. All the findings will facilitate the development of novel therapeutic approaches.

Tumor Suppressor Gene P53 and Autophagy

p53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment.

p53 tumor suppressor and iron homeostasis.

TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy.

XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling.

The dual functions of P53 in the regulation of autophagy

Progress and Prospects: Roles of P53 in Tumor Development

Relationship Between Autophagy and Tumorigenesis

Targeting p53 pathways: mechanisms, structures, and advances in therapy

p53 signaling in cancer progression and therapy

p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies

Regulation of P53 Stability As a Therapeutic Strategy for Cancer.

P53 and Regulation of Tumor Metabolism

P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds

Multiple roles of p53 in cancer development: Regulation of tumor microenvironment, m6A modification and diverse cell death mechanisms

Emerging Roles of the Tumor Suppressor p53 in Metabolism

Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy

A Glance of p53 Functions in Brain Development, Neural Stem Cells, and Brain Cancer

P53 Mutation and Deletion Contribute to Tumor Immune Evasion

Retracted: P53 Suppresses Stress-Induced Cellular Senescence Via Regulation Of Autophagy Under The Deprivation Of Serum (Retracted Article. See Vol. 22, Pg. 4079, 2020)

The interaction between malate dehydrogenase and p53 protein contribute to tumor progression